Loading…

Clinical and Cost Implications of Clinical Pharmacist Interventions on Antimicrobial Use at Sultan Qaboos University Hospital in Oman

•Most interventions were significant and associated with improved efficacy.•Cost-saving of $200,000 USD/year was estimated as a result of the interventions.•Clinical pharmacists play a crucial role in antimicrobial stewardship. To evaluate the clinical and financial impact of clinical pharmacists’ i...

Full description

Saved in:
Bibliographic Details
Published in:International journal of infectious diseases 2021-08, Vol.109, p.137-141
Main Authors: Salman, Bushra, Al-Hashar, Amna, Al-Khirbash, Athar, Al-Zakwani, Ibrahim
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c443t-8e119c79e20de430e06d938aad5feb16775b3c9632b2cfe7fed48ace886910003
cites cdi_FETCH-LOGICAL-c443t-8e119c79e20de430e06d938aad5feb16775b3c9632b2cfe7fed48ace886910003
container_end_page 141
container_issue
container_start_page 137
container_title International journal of infectious diseases
container_volume 109
creator Salman, Bushra
Al-Hashar, Amna
Al-Khirbash, Athar
Al-Zakwani, Ibrahim
description •Most interventions were significant and associated with improved efficacy.•Cost-saving of $200,000 USD/year was estimated as a result of the interventions.•Clinical pharmacists play a crucial role in antimicrobial stewardship. To evaluate the clinical and financial impact of clinical pharmacists’ interventions (CPIs) on antimicrobial use at a 500-bed multidisciplinary tertiary care hospital in Oman. A retrospective analysis of CPIs related to antimicrobials use at Sultan Qaboos University Hospital (SQUH) from January to December 2018. Interventions were recorded using an electronic CPI form and were reviewed by two independent CPs. Data on the type and clinical significance of the interventions were extracted. Cost analysis was done using a previously defined cost avoidance model in addition to direct cost reduction estimation. Descriptive data were used to describe the results. In 2018, 26% of CPIs were related to antimicrobial use, with more than 60% of these interventions done on intensive care unit patients. The most common intervention type was adjusting the dosing regimen (42% of the total interventions), followed by deletion of the antimicrobial order in 34% of the cases. The most common clinical impact of CPIs was improving efficacy in 45% of the interventions, followed by preventing unnecessary exposure to the antimicrobials in around 30% of the interventions. The interventions were of major significance in 64% of the cases. This translated into a projected net cost saving of approximately $200,000 USD/year. CPs interventions on antimicrobial use had a positive impact on both the clinical and financial outcomes.
doi_str_mv 10.1016/j.ijid.2021.07.002
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a9141688a07c43d6ba22118b8f13f669</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1201971221005579</els_id><doaj_id>oai_doaj_org_article_a9141688a07c43d6ba22118b8f13f669</doaj_id><sourcerecordid>2550261064</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-8e119c79e20de430e06d938aad5feb16775b3c9632b2cfe7fed48ace886910003</originalsourceid><addsrcrecordid>eNp9kcGO0zAQhiMEEsvCC3DykUuDx0kdR-KyqmC30koLgp6tiTOBqRK72G6lfQDeG5eu9shpRqPv_8eev6reg6xBgv64r3nPY62kglp2tZTqRXUFpjOrZg3wsvRKwqrvQL2u3qS0l1K2Wpur6s9mZs8OZ4F-FJuQstguh7lMMgefRJjEM_H1F8YFHZ8ZnymeyD9BXtyUdmEXw8CF3CUSmMX345zRi284hJDEzvOJYuL8KO5COnAuIHvxsKB_W72acE707qleV7svn39s7lb3D7fbzc39yrVtk1eGAHrX9aTkSG0jSeqxbwziuJ5oAN1166FxvW7UoNxE3URja9CRMbqH8uXmutpefMeAe3uIvGB8tAHZ_huE-NNizOxmsthDC9oYlJ1rm1EPqBSAGcwEzaR1X7w-XLwOMfw-Usp24eRontFTOCar1mupNEjdFlRd0HKflCJNz6tB2nN-dm_P-dlzflZ2tuRXRJ8uIioHOTFFmxyTdzRyJJfLi_l_8r8dlaTi</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2550261064</pqid></control><display><type>article</type><title>Clinical and Cost Implications of Clinical Pharmacist Interventions on Antimicrobial Use at Sultan Qaboos University Hospital in Oman</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><source>ScienceDirect Journals</source><creator>Salman, Bushra ; Al-Hashar, Amna ; Al-Khirbash, Athar ; Al-Zakwani, Ibrahim</creator><creatorcontrib>Salman, Bushra ; Al-Hashar, Amna ; Al-Khirbash, Athar ; Al-Zakwani, Ibrahim</creatorcontrib><description>•Most interventions were significant and associated with improved efficacy.•Cost-saving of $200,000 USD/year was estimated as a result of the interventions.•Clinical pharmacists play a crucial role in antimicrobial stewardship. To evaluate the clinical and financial impact of clinical pharmacists’ interventions (CPIs) on antimicrobial use at a 500-bed multidisciplinary tertiary care hospital in Oman. A retrospective analysis of CPIs related to antimicrobials use at Sultan Qaboos University Hospital (SQUH) from January to December 2018. Interventions were recorded using an electronic CPI form and were reviewed by two independent CPs. Data on the type and clinical significance of the interventions were extracted. Cost analysis was done using a previously defined cost avoidance model in addition to direct cost reduction estimation. Descriptive data were used to describe the results. In 2018, 26% of CPIs were related to antimicrobial use, with more than 60% of these interventions done on intensive care unit patients. The most common intervention type was adjusting the dosing regimen (42% of the total interventions), followed by deletion of the antimicrobial order in 34% of the cases. The most common clinical impact of CPIs was improving efficacy in 45% of the interventions, followed by preventing unnecessary exposure to the antimicrobials in around 30% of the interventions. The interventions were of major significance in 64% of the cases. This translated into a projected net cost saving of approximately $200,000 USD/year. CPs interventions on antimicrobial use had a positive impact on both the clinical and financial outcomes.</description><identifier>ISSN: 1201-9712</identifier><identifier>EISSN: 1878-3511</identifier><identifier>DOI: 10.1016/j.ijid.2021.07.002</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>Antibiotics ; antimicrobial stewardship ; cost savings ; inappropriate prescribing ; Oman</subject><ispartof>International journal of infectious diseases, 2021-08, Vol.109, p.137-141</ispartof><rights>2021 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-8e119c79e20de430e06d938aad5feb16775b3c9632b2cfe7fed48ace886910003</citedby><cites>FETCH-LOGICAL-c443t-8e119c79e20de430e06d938aad5feb16775b3c9632b2cfe7fed48ace886910003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1201971221005579$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,778,782,3538,27907,27908,45763</link.rule.ids></links><search><creatorcontrib>Salman, Bushra</creatorcontrib><creatorcontrib>Al-Hashar, Amna</creatorcontrib><creatorcontrib>Al-Khirbash, Athar</creatorcontrib><creatorcontrib>Al-Zakwani, Ibrahim</creatorcontrib><title>Clinical and Cost Implications of Clinical Pharmacist Interventions on Antimicrobial Use at Sultan Qaboos University Hospital in Oman</title><title>International journal of infectious diseases</title><description>•Most interventions were significant and associated with improved efficacy.•Cost-saving of $200,000 USD/year was estimated as a result of the interventions.•Clinical pharmacists play a crucial role in antimicrobial stewardship. To evaluate the clinical and financial impact of clinical pharmacists’ interventions (CPIs) on antimicrobial use at a 500-bed multidisciplinary tertiary care hospital in Oman. A retrospective analysis of CPIs related to antimicrobials use at Sultan Qaboos University Hospital (SQUH) from January to December 2018. Interventions were recorded using an electronic CPI form and were reviewed by two independent CPs. Data on the type and clinical significance of the interventions were extracted. Cost analysis was done using a previously defined cost avoidance model in addition to direct cost reduction estimation. Descriptive data were used to describe the results. In 2018, 26% of CPIs were related to antimicrobial use, with more than 60% of these interventions done on intensive care unit patients. The most common intervention type was adjusting the dosing regimen (42% of the total interventions), followed by deletion of the antimicrobial order in 34% of the cases. The most common clinical impact of CPIs was improving efficacy in 45% of the interventions, followed by preventing unnecessary exposure to the antimicrobials in around 30% of the interventions. The interventions were of major significance in 64% of the cases. This translated into a projected net cost saving of approximately $200,000 USD/year. CPs interventions on antimicrobial use had a positive impact on both the clinical and financial outcomes.</description><subject>Antibiotics</subject><subject>antimicrobial stewardship</subject><subject>cost savings</subject><subject>inappropriate prescribing</subject><subject>Oman</subject><issn>1201-9712</issn><issn>1878-3511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kcGO0zAQhiMEEsvCC3DykUuDx0kdR-KyqmC30koLgp6tiTOBqRK72G6lfQDeG5eu9shpRqPv_8eev6reg6xBgv64r3nPY62kglp2tZTqRXUFpjOrZg3wsvRKwqrvQL2u3qS0l1K2Wpur6s9mZs8OZ4F-FJuQstguh7lMMgefRJjEM_H1F8YFHZ8ZnymeyD9BXtyUdmEXw8CF3CUSmMX345zRi284hJDEzvOJYuL8KO5COnAuIHvxsKB_W72acE707qleV7svn39s7lb3D7fbzc39yrVtk1eGAHrX9aTkSG0jSeqxbwziuJ5oAN1166FxvW7UoNxE3URja9CRMbqH8uXmutpefMeAe3uIvGB8tAHZ_huE-NNizOxmsthDC9oYlJ1rm1EPqBSAGcwEzaR1X7w-XLwOMfw-Usp24eRontFTOCar1mupNEjdFlRd0HKflCJNz6tB2nN-dm_P-dlzflZ2tuRXRJ8uIioHOTFFmxyTdzRyJJfLi_l_8r8dlaTi</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Salman, Bushra</creator><creator>Al-Hashar, Amna</creator><creator>Al-Khirbash, Athar</creator><creator>Al-Zakwani, Ibrahim</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>202108</creationdate><title>Clinical and Cost Implications of Clinical Pharmacist Interventions on Antimicrobial Use at Sultan Qaboos University Hospital in Oman</title><author>Salman, Bushra ; Al-Hashar, Amna ; Al-Khirbash, Athar ; Al-Zakwani, Ibrahim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-8e119c79e20de430e06d938aad5feb16775b3c9632b2cfe7fed48ace886910003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibiotics</topic><topic>antimicrobial stewardship</topic><topic>cost savings</topic><topic>inappropriate prescribing</topic><topic>Oman</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salman, Bushra</creatorcontrib><creatorcontrib>Al-Hashar, Amna</creatorcontrib><creatorcontrib>Al-Khirbash, Athar</creatorcontrib><creatorcontrib>Al-Zakwani, Ibrahim</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salman, Bushra</au><au>Al-Hashar, Amna</au><au>Al-Khirbash, Athar</au><au>Al-Zakwani, Ibrahim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical and Cost Implications of Clinical Pharmacist Interventions on Antimicrobial Use at Sultan Qaboos University Hospital in Oman</atitle><jtitle>International journal of infectious diseases</jtitle><date>2021-08</date><risdate>2021</risdate><volume>109</volume><spage>137</spage><epage>141</epage><pages>137-141</pages><issn>1201-9712</issn><eissn>1878-3511</eissn><abstract>•Most interventions were significant and associated with improved efficacy.•Cost-saving of $200,000 USD/year was estimated as a result of the interventions.•Clinical pharmacists play a crucial role in antimicrobial stewardship. To evaluate the clinical and financial impact of clinical pharmacists’ interventions (CPIs) on antimicrobial use at a 500-bed multidisciplinary tertiary care hospital in Oman. A retrospective analysis of CPIs related to antimicrobials use at Sultan Qaboos University Hospital (SQUH) from January to December 2018. Interventions were recorded using an electronic CPI form and were reviewed by two independent CPs. Data on the type and clinical significance of the interventions were extracted. Cost analysis was done using a previously defined cost avoidance model in addition to direct cost reduction estimation. Descriptive data were used to describe the results. In 2018, 26% of CPIs were related to antimicrobial use, with more than 60% of these interventions done on intensive care unit patients. The most common intervention type was adjusting the dosing regimen (42% of the total interventions), followed by deletion of the antimicrobial order in 34% of the cases. The most common clinical impact of CPIs was improving efficacy in 45% of the interventions, followed by preventing unnecessary exposure to the antimicrobials in around 30% of the interventions. The interventions were of major significance in 64% of the cases. This translated into a projected net cost saving of approximately $200,000 USD/year. CPs interventions on antimicrobial use had a positive impact on both the clinical and financial outcomes.</abstract><pub>Elsevier Ltd</pub><doi>10.1016/j.ijid.2021.07.002</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1201-9712
ispartof International journal of infectious diseases, 2021-08, Vol.109, p.137-141
issn 1201-9712
1878-3511
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_a9141688a07c43d6ba22118b8f13f669
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS; ScienceDirect Journals
subjects Antibiotics
antimicrobial stewardship
cost savings
inappropriate prescribing
Oman
title Clinical and Cost Implications of Clinical Pharmacist Interventions on Antimicrobial Use at Sultan Qaboos University Hospital in Oman
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T05%3A12%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20and%20Cost%20Implications%20of%20Clinical%20Pharmacist%20Interventions%20on%20Antimicrobial%20Use%20at%20Sultan%20Qaboos%20University%20Hospital%20in%20Oman&rft.jtitle=International%20journal%20of%20infectious%20diseases&rft.au=Salman,%20Bushra&rft.date=2021-08&rft.volume=109&rft.spage=137&rft.epage=141&rft.pages=137-141&rft.issn=1201-9712&rft.eissn=1878-3511&rft_id=info:doi/10.1016/j.ijid.2021.07.002&rft_dat=%3Cproquest_doaj_%3E2550261064%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c443t-8e119c79e20de430e06d938aad5feb16775b3c9632b2cfe7fed48ace886910003%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2550261064&rft_id=info:pmid/&rfr_iscdi=true